Bolt Biotherapeutics Inc BOLT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 01/14/22 EST
3.96UNCH (UNCH)
Volume
16,903
Close
3.96quote price arrow up+0.17 (+4.49%)
Volume
264,665
52 week range
3.43 - 43.07
Loading...
  • Open3.75
  • Day High3.99
  • Day Low3.59
  • Prev Close3.79
  • 52 Week High43.07
  • 52 Week High Date03/11/21
  • 52 Week Low3.43
  • 52 Week Low Date01/13/22

Key Stats

  • Market Cap147.63M
  • Shares Out37.28M
  • 10 Day Average Volume0.31M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-19.18

KEY STATS

  • Open3.75
  • Day High3.99
  • Day Low3.59
  • Prev Close3.79
  • 52 Week High43.07
  • 52 Week High Date03/11/21
  • 52 Week Low3.43
  • 52 Week Low Date01/13/22
  • Market Cap147.63M
  • Shares Out37.28M
  • 10 Day Average Volume0.31M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-19.18

RATIOS/PROFITABILITY

  • EPS (TTM)-3.15
  • P/E (TTM)-1.26
  • Fwd P/E (NTM)-1.38
  • EBITDA (TTM)-81.554M
  • ROE (TTM)-102.30%
  • Revenue (TTM)750,000.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-13,626.20%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date03/31/2022
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Bolt Biotherapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
Bolt Biotherapeutics, Inc is a clinical-stage immuno-oncology company. The Company is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. Its Immune-Stimulating Antibody Conjugate (ISAC) approach uses immunostimulants to engage and activate myeloid cells, including macrophages and dendritic cells, that kill tumor cells via phagocytosis and expose tumor neoantigens to the adaptive immune system. The Company’s product candidate...
Randall Schatzman Ph.D.
Chief Executive Officer, Director
William Quinn
Chief Financial Officer
Address
900 Chesapeake Drive
Redwood City, CA
94063
United States

Top Peers

SYMBOLLASTCHG%CHG
ATNM
Actinium Pharmaceuticals Inc
5.80+0.10+1.75%
TNXP
Tonix Pharmaceuticals Holding Corp
0.286-0.0013-0.4525%
DARE
Dare Bioscience Inc
1.66+0.10+6.41%
GMDA
Gamida Cell Ltd
2.27-0.05-2.16%
BCLI
Brainstorm Cell Therapeutics Inc
3.55+0.12+3.50%